Pharmigene, Inc. develops, manufactures, and sells diagnostic tests worldwide. The company primarily develops DNA genetic tests. It also offers molecular diagnostics related products to test adverse drug reactions. The company was founded in 2005 and is headquartered in Taipei, Taiwan.
Stock data | 2024 | Change |
---|---|---|
Price | $0.39756810647485535 | N/A |
Market Cap | $20.06M | N/A |
Shares Outstanding | 50.47M | N/A |
Employees | 0 | N/A |